CCAP.L Regulatory News (CCAP)

25 Apr 2007 07:00

Charlemagne Capital Limited25 April 2007 25th April 2007 Purchase of own shares for cancellation Charlemagne Capital Limited ("Charlemagne", the "Company") announces that onTuesday 24th April 2007 it purchased for cancellation 700,000 Ordinary Shares ofUS$0.01 each in the Company through UBS Limited at a price, before expenses, of75.5 pence. As a result of these purchases and cancellations, Charlemagne will have290,404,872 Ordinary Shares of US$0.01 each in issue. At its Annual General Meeting held on 22 May 2006, Charlemagne was authorised byits shareholders to purchase up to 29,771,177 of its ordinary shares(representing 10% of its issued capital at that time) subject to certainconditions as outlined in the resolution. Enquiries Charlemagne Capital 01624 640200David McMahon, Company Secretary Smithfield Consultants 020 7360 4900John KielyGeorge Hudson Notes to editors Charlemagne Capital is a specialist emerging markets equity investmentmanagement group. Charlemagne Capital Limited was admitted to the AIM market ofthe London Stock Exchange on 4 April 2006. Charlemagne's product range comprises mutual funds, hedge funds andinstitutional and specialist fund products primarily covering GEMs, EasternEurope, Latin America and Asia. Charlemagne Capital employs a range ofinvestment strategies including: long only, long/short, structured products andprivate equity. Charlemagne Capital's funds aim to exploit the inefficiencies inthe market via a strict bottom up approach and focused stock selection. This information is provided by RNS The company news service from the London Stock Exchange